Yunkang Group Limited provided earnings guidance for the six months ended June 30, 2022. For the period, the company expects its net profits to increase by 40% to 50% as compared to that of the corresponding period in previous financial year. The Board considers that this is mainly attributable to the significant increase in revenue generated from the Company's diagnostic testing services for medical institution alliances, which has a positive impact on the profitability of the Company.